Zacks Investment Research on MSN
OraSure files for FDA review of molecular self-test & Colli-Pee device
OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...
TipRanks on MSN
IMDx prepares for US commercial launch of GraftAssureDx
Insight Molecular Diagnostics (IMDX) provided a year-end business update regarding its commercial progress, its GraftAssureDx test kit clinical ...
A 2022 study estimates that at-home flu tests have a sensitivity of about 63% if the test is performed within 72 hours of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback